Figure 1: Pharmaceutical Market, Germany, Revenue ($B and €B), 2013-2020
Figure 2: Medical Devices Market, Germany, Revenue ($B), 2017-2022
Figure 3: Healthcare Startups in Germany, 2020
Figure 4: Country Profile, Germany, 2020
Figure 5: Pharmaceutical Market, Germany, Revenue ($B), 2012-2019
Figure 6: Pharmaceutical Market, Germany, Revenue Forecast ($B), 2020-2025
Figure 7: Pharmaceutical Exports ($B), Germany, 2012-2020
Figure 8: Top Export Partners, Germany, 2020
Figure 9: Pharmaceutical Imports ($B), Germany, 2012-2020
Figure 10: Top Import Partners, Germany, 2020
Figure 11: Generic Drugs (Market share % by value and volume), Germany, 2010-2018
Figure 12: Generic Drug Marketing Authorization Applications (Number), EU, 2015-2021
Figure 13: Biotechnology SME Share (%), Germany, 2020
Figure 14: OTC Medicines Market, Revenue ($B), Germany, 2013-2020
Figure 15: OTC Medicines Market, Major Categories ($M), Germany, 2020
Figure 16: OTC Medicines Market, Major Distribution Channels ($M), Germany, 2017
Figure 17: Pharmaceutical Sales by Drug Category ($B), Germany, 2019
Figure 18: Major Therapeutic Areas by Pharmaceutical Consumption (DDD per million inhabitants), Germany, 2016-2018
Figure 19: COVID-19 (Number of cases), Germany, 2020-2021
Figure 20: COVID-19 (Number of deaths), Germany, 2020-2021
Figure 21: COVID-19 Risk Areas Classification, Germany, 2020-2021
Figure 22: COVID-19 Fiscal Stimulus Timeline, Germany, 2020-2021
Figure 23: COVID-19 Vaccination Priority Groups, Germany, 2020-2021
Figure 24: COVID-19 Vaccine Administration, Number of People, Germany, 2020-2021
Figure 25: Top COVID-19 Marketed Products by Category (Number of available marketed products), Germany, 2020-2021
Figure 26: Top COVID-19 IVD Products by Equipment Type (Number of available marketed products), Germany, 2020-2021
Figure 27: Top COVID-19 Marketed Products by Product Class (Number of available marketed products), Germany, 2020-2021
Figure 28: Top COVID-19 Anesthesia and Respiratory Devices Products by Equipment Type (Number of available marketed products), Germany, 2020-2021
Figure 29: COVID-19 Clinical Trials Count by Phase, Germany, 2020-2021
Figure 30: COVID-19 Clinical Trials Count by Trial Status, Germany, 2020-2021
Figure 31: Top Five COVID-19 Clinical Trials Sponsors by Count, Germany, 2020-2021
Figure 32: Pharmaceutical Market, Major Players, 2020
Figure 33: Medical Devices Market, Germany, Revenue ($B), 2015-2020
Figure 34: Medical Devices Market, Germany, Revenue Forecast ($B), 2021-2025
Figure 35: Medical Devices Market, Germany, Major Segments (%), 2020
Figure 36: General Surgery Devices Market, Germany, Revenue ($B), 2017-2025
Figure 37: General Surgery Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 38: Cardiovascular Devices Market, Germany, Revenue ($B), 2017-2025
Figure 39: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 40: Healthcare IT Market, Germany, Revenue ($B), 2017-2025
Figure 41: Healthcare IT Market, Germany, Market Share of Major Players (%), 2018
Figure 42: Orthopedic Devices Market, Germany, Revenue ($B), 2017-2025
Figure 43: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2020
Figure 44: In Vitro Diagnostics Market, Germany, Revenue ($B), 2017-2025
Figure 45: In Vitro Diagnostics Market, Germany, Market Share of Major Players (%), 2020
Figure 46: Diagnostic Market, Germany, Revenue ($B), 2015-2020
Figure 47: Diagnostic Market, Germany, Revenue ($B), 2021-2025
Figure 48: Medical Devices Market, Germany, Revenue ($B) of Major Companies, 2020
Figure 49: Deal Value and Deal Count, Pharmaceutical Market, Germany, 2020-2021
Figure 50: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Germany, 2020-2021
Figure 51: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Germany, 2020-2021
Figure 52: Top Therapy Areas by Deal Value, Pharmaceutical Market, Germany, 2020-2021
Figure 53: Top Therapy Areas by Deal Count, Pharmaceutical Market, Germany, 2020-2021
Figure 54: M&A Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number)
Figure 55: VC Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number)
Figure 56: Deal Value and Deal Count, Medical Devices Market, Germany, 2020-2021
Figure 57: Deal Value and Deal Count, Quarterly, Medical Devices Market, Germany, 2020-2021
Figure 58: Deal Value and Deal Count Sub-types, Medical Devices Market, Germany, 2020-2021
Figure 59: Top Equipment Sectors by Deal Value, Medical Devices Market, Germany, 2020-2021
Figure 60: Top Equipment Sectors by Deal Count, Medical Devices Market, Germany, 2020-2021
Figure 61: M&A Deals by Equipment Sector, Medical Devices Market, Germany, 2020-2021 (by value and by number)
Figure 62: VC Deals by Quarter, Medical Devices Market, Germany, 2020-2021 (by value and by number)
Figure 63: Digital Hubs under the Digital Initiative, Germany, 2021
Figure 64: Deal Value ($M), HealthTech, Germany, 2020-2021
Figure 65: Deal Count (Number of Deals), HealthTech, Germany, 2020-2021
Figure 66: DiGA Approval Process, Germany, 2021
Figure 67: GDPR Compliance Checklist, EU, 2021
Figure 68: Overview of Healthcare System, Germany, 2020
Figure 69: Key Reimbursement Stakeholders, Germany, 2020
Figure 70: Six-level Benefit Scale, Germany, 2020
Figure 71: Drug Reimbursement Process, Germany, 2020
Figure 72: Medical Device Reimbursement Process, Germany, 2020
Figure 73: Health Insurance Covered Population (% of population), Germany, 2020
Figure 74: Number of SHI Providers, Germany, 2013-2021
Figure 75: Additional Contribution Rate (%), Germany, 2015-2021
Figure 76: Private Health Insurance Coverage (% of population), Germany, 2015-2019
Figure 77: Out-of-Pocket Spending ($ per capita), Germany, 2012-2019
Figure 78: Health Price Index (2015 = 100), Germany, 2012-2021
Figure 79: AMNOG Process, Germany, 2020
Figure 80: Federal Institute for Drugs and Medical Devices, Organization Chart, 2021
Figure 81: Drug Authorization Procedures, EU, 2020
Figure 82: Centralized Procedure, Germany, 2020
Figure 83: Mutual Recognition Procedure, Germany, 2019
Figure 84: Decentralized Procedure, Germany, 2019
Figure 85: Generic Drug Authorization Procedures, EU, 2020
Figure 86: Biologic vs Biosimilar Approval Process, Germany, 2020
Figure 87: Conformity Assessment of Class I Medical Devices, EU, 2019
Figure 88: Conformity Assessment of Class IIa Medical Devices, EU, 2019
Figure 89: Conformity Assessment of Class IIb Medical Devices, EU, 2019
Figure 90: Conformity Assessment of Class III Medical Devices, EU, 2019
Figure 91: Patent Approval Process, Germany, 2020
Figure 92: Clinical Trial Approval Process, Germany, 2020
Figure 93: Pharmaceutical Clinical Trials Count by Trial Status, Germany, 2020-2021
Figure 94: Pharmaceutical Clinical Trials Count by Trial Status, Germany, 2020-2021
Figure 95: Pharmaceutical Clinical Trials Count by Therapy Area, Germany, 2020-2021
Figure 96: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Germany, 2020-2021
Figure 97: Medical Devices Clinical Trials Count by Trial Status, Germany, 2020-2021
Figure 98: Medical Devices Clinical Trials Count by Indication, Germany, 2020-2021
Figure 99: Medical Devices Clinical Trials Count by Device Category, Germany, 2020-2021
Figure 100: Top Medical Devices Clinical Trials Sponsors by Count, Germany, 2020-2021
Figure 101: Number of Hospitals, Germany, 2011-2018
Figure 102: Number of Diagnostic Equipment Units (installed base), Germany, 2015-2020
Figure 103: Number of Hospital Beds (per 1,000 Population), Germany, 2011-2018
Figure 104: Number of Acute Care Beds (per 1,000 Population), Germany, 2011-2018
Figure 105: Number of Psychiatric Care Beds (per 1,000 Population), Germany, 2011-2018
Figure 106: Life Expectancy at Birth (Years), Germany, 2011-2018
Figure 107: Immunization Rate (% of children immunized), Germany, 2011-2018
Figure 108: PM2.5 (µg per m3), Germany, 2011-2019
Figure 109: CO2 Emissions (Mt CO2), Germany, 2011-2019
Figure 110: Physicians (per 1,000 Population), Germany, 2011-2019
Figure 111: Dentists (per 1,000 Population), Germany, 2011-2018
Figure 112: Pharmacists (per 1,000 Population), Germany, 2011-2018
Figure 113: Nurses (per 1,000 Population), Germany, 2011-2018
Figure 114: Major Causes of Mortality (number of deaths), Germany, 2019
Figure 115: Major Causes of Male Mortality (number of deaths), Germany, 2019
Figure 116: Major Causes of Female Mortality (number of deaths), Germany, 2019
Figure 117: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Germany, 2019
Figure 118: Healthcare Expenditure as Percentage of GDP (%), Germany, 2011-2019
Figure 119: Healthcare Spending (Government vs. Voluntary Share), Germany, 2011-2019
Figure 120: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Germany, 2018
Figure 121: Pharmaceutical Spending ($ per capita), Germany, 2011-2018
Figure 122: Opportunities and Challenges